PATENT CLAIM ANALYSIS

Application Number: 16210034
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["424", "616000"]

Abstract:
There is provided a method for treating rosacea comprising a composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.

Claim (Index 43):
A method for treating a pigmented lesion comprising:\n a) topically applying on the pigmented lesion, a composition comprising at least one oxidant and Eosin Y; and b) exposing said composition to actinic light having an emission wavelength between about 400 nm and about 600 nm for a time sufficient to activate said oxidant.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.34211
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13770907', '14137599', '13127445', '14540484', '15162801']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.810234251455151
- 35 USC 102 Novelty (BERT): 0.5429469931895254
- Combined Prediction Score: 0.7835055256285886
- Mean Citation Score: 384.992734
- Max Citation Score: 391.19693
- Similarity Product: 327.42887398140374

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test